Rodan & Fields will present four scientific posters at this year’s American Academy of Dermatology (AAD) Annual Meeting in Washington, D.C.
The work highlighted in the posters, developed by Stanford-trained dermatologists and founders of Rodan + Fields, Dr. Katie Rodan and Dr. Kathy Fields, and a team of scientists led by Chief Scientific Officer Dr. Timothy Falla, showcases the research behind the company’s teen acne solution, SPOTLESS, along with work on facial and body skin hydration, and the positive synergistic impact of calcium and retinal for multiple skin benefits.
“We are delighted to share our latest research at the Academy’s Annual Meeting,” said Dr. Falla. “We’ve seen extraordinary results in our clinical studies, and this further validates our scientific leadership and commitment to developing innovative products that provide meaningful results.”
The teen and young adult acne treatment research poster being presented at AAD details an eight-week clinical study on the efficacy and safety of a two-step acne regimen developed by Rodan + Fields utilizing a patent-pending delivery system designed for teenage subjects, leveraging benzoyl peroxide in an innovative liquid form.
The research highlights the work that went into the launch of Rodan + Fields new SPOTLESS regimen, which features a novel BPO2 technology to penetrate stubborn biofilms and balance the microbiome inside pores to effectively combat the entire acne cycle.
The eight-week clinical study of male and female teenagers with mild-to-moderate acne assessed the efficacy and safety of the regimen. With benefits beginning from first use, 97 percent of those in the study reported significant improvement in overall blemish appearance. In addition, this regimen provided faster onset of benefits and was less irritating than competitor products utilizing benzoyl peroxide.
The AAD Annual Meeting is the largest annual gathering of dermatologists in the world, with more than 18,000 attendees. This year’s meeting is being held March 1-5.
